Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients

Ye Bin; Zhu Xiangying; Zeng Zhifu; Ji Xiaozhen; Ji Meixia

doi:10.1515/pteridines-2020-0025

Pteridines (Mar 2021)

Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients

Ye Bin,
Zhu Xiangying,
Zeng Zhifu,
Ji Xiaozhen,
Ji Meixia

Affiliations

Ye Bin: Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Zhu Xiangying: Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Zeng Zhifu: Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Ji Xiaozhen: Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Ji Meixia: Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China

DOI: https://doi.org/10.1515/pteridines-2020-0025
Journal volume & issue: Vol. 32, no. 1
pp. 11 – 16

Abstract

Read online

The aim of this study was to investigate the clinical significance of serum homocysteine (Hcy) as a biomarker for early diagnosis of diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM) patients.

Published in Pteridines

ISSN: 0933-4807 (Print); 2195-4720 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Science: Chemistry: Crystallography
Website: https://www.degruyter.com/view/j/pteridines

About the journal

Abstract

Keywords